人类乳头状瘤病毒16抗体

英文名称 HPV16 E6 protein
中文名称 人类乳头状瘤病毒16抗体
别 名 E6; HPV16 E6 protein; Human Papilloma Virus; Human papillomavirus type 16 E6; Human papillomavirus type 16; Protein E6; E6 protein; HPV16 E6; HPV16-E6; VE6_HPV16.
人类乳头状瘤病毒16抗体
说 明 书 0.2ml
研究领域
抗体来源 Mouse
克隆类型 Monoclonal
交叉反应 HPV16
产品应用 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
人类乳头状瘤病毒16抗体
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 11kDa
性 状 Lyophilized or Liquid
浓 度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from HPV16 E6 protein
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
生 产 商 BIOSS
PubMed PubMed
产品介绍 background:
Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.

Function:
Plays a major role in the induction and maintenance of cellular transformation. Acts mainly as an oncoprotein by stimulating the destruction of many host cell key regulatory proteins. E6 associates with host E6-AP ubiquitin-protein ligase, and inactivates tumor suppressors TP53 and TP73 by targeting them to the 26S proteasome for degradation. In turn, DNA damage and chromosomal instabilities increase and lead to cell proliferation and cancer development. The complex E6/E6P targets several other substrates to degradation via the proteasome including host NFX1-91, a repressor of human telomerase reverse transcriptase (hTERT). The resulting increased expression of hTERT prevents the shortening of telomere length leading to cell immortalization. Other cellular targets including Bak, Fas-associated death domain-containing protein (FADD) and procaspase 8, are degraded by E6/E6AP causing inhibition of apoptosis. E6 also inhibits immune response by interacting with host IRF3 and TYK2. These interactions prevent IRF3 transcriptional activities and inhibit TYK2-mediated JAK-STAT activation by interferon alpha resulting in inhibition of the interferon signaling pathway.

Subunit:
Forms a complex E6-AP ubiquitin-protein ligase which interacts with human TP53. Binds to human FBLN1 and MPDZ (By similarity). Interacts with human NFX1 and MAGI3. Interacts with human IRF3; this interaction inhibits the establishment of antiviral state. Interacts with human TYK2; this interaction inhibits JAK-STAT activation by interferon alpha.
人类乳头状瘤病毒16抗体
zk-12958R phospho-Aconitase 1 (Ser711)磷酸化铁调节蛋白1抗体
zk-12952R phospho-Acetyl Coenzyme A Carbozklase beta (Ser220)磷酸化乙酰辅酶A羧化酶抗体
zk-8997R Annexin VI膜粘连蛋白6抗体
zk-9401R ANKRD42锚蛋白重复结构域蛋白42抗体
zk-7738R Anillin胞环蛋白肌动蛋白结合蛋白抗体
zk-7697R Adenovirus 5 E1A binding protein腺病毒5结合蛋白BS69抗体(骨形态发生蛋白受体相关分子1)
zk-2314R APOA1载脂蛋白A1抗体
zk-4007R ATG16L自噬相关蛋白16A抗体
zk-5201R phospho-ATG4D(Ser15)磷酸化自噬相关蛋白4D抗体
zk-5196R Phospho-ATG4C(Ser451)磷酸化自噬相关蛋白4C抗体
zk-5197R phospho-ATG7(Ser95)磷酸化自噬相关蛋白7抗体
zk-5198R phospho-ATG16A(Ser287)磷酸化自噬相关蛋白16A抗体
zk-5199R phospho-ATG9A(Ser735)磷酸化自噬相关蛋白9A抗体
zk-5202R phospho-ATG4D(Ser341)磷酸化自噬相关蛋白4D抗体
zk-5203R phospho-ATG4D(Ser467)磷酸化自噬相关蛋白4D抗体
zk-5210R phospho-TEM8 (Tyr382)磷酸化肿瘤血管内皮标志物8抗体
zk-5207R phospho-ATG4A(Ser100)磷酸化自噬相关蛋白4A抗体
zk-5208R phospho-ATG4C(Ser166)磷酸化自噬相关蛋白4C抗体
zk-5206R phospho-ATG16A(Ser213)磷酸化自噬相关蛋白16A抗体
zk-5209R phospho-AKT3 (Ser472)磷酸化蛋白激酶AKT3抗体
zk-5211R phospho-ADRB2 (Ser261)磷酸化肾 上 腺 素能受体β2抗体
zk-5214R phospho-AQP2(Ser261)磷酸化水通道蛋白2抗体
zk-5204R phospho-ATG3 (Tyr18)磷酸化自噬相关蛋白3抗体